Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2009 - 2026)

Updated

Elite Pharmaceuticals' Return on Equity [ROE] was 53.12% in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 27.79 percentage points from 25.33% a year earlier but down 2.52 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Equity [ROE] at Elite Pharmaceuticals came in at 58.89%, up 66.81 percentage points from FY2025.

  • Return on Equity [ROE] shows a five-year change of +7070.01 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Equity [ROE] was -7.92% in FY2025 (-54.48 pp), 46.56% in FY2024 (+33.41 pp), 13.15% in FY2023 (-25.72 pp) and 38.87% in FY2022 (+7049.99 pp).
  • Quarterly Return on Equity [ROE] has moved between -4336.94% (fiscal Q3 2022) and 61.06% (fiscal Q3 2026) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for five straight quarters, with an average year-over-year change of +15.67 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q4 2022 (a gain of 5761.03 percentage points); the worst was fiscal Q3 2022 (a drop of 4378.59 percentage points).
  • Per Business Quant data, ELTP's Return on Equity [ROE] in the three fiscal quarters before Q2 2027 was 55.64% (Q1 2027), 50.08% (Q4 2026) and 61.06% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 19.33%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.63%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 21.60%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -31.17%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.66%
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 53.12%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 53.12%
Jun 30, 2026 55.64%
Mar 31, 2026 50.08%
Dec 31, 2025 61.06%
Sep 30, 2025 25.33%
Jun 30, 2025 -21.54%
Mar 31, 2025 -9.78%
Dec 31, 2024 -42.88%
Sep 30, 2024 -12.04%
Jun 30, 2024 33.88%
Mar 31, 2024 38.74%
Dec 31, 2023 33.99%
Sep 30, 2023 47.38%
Jun 30, 2023 14.89%
Mar 31, 2023 12.04%
Dec 31, 2022 25.17%
Sep 30, 2022 24.78%
Jun 30, 2022 26.85%
Mar 31, 2022 33.50%
Dec 31, 2021 -4,336.94%
API Access

Elite Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY